Disease progression and liver cancer in the ferroportin disease [15]

Gut

Volumn 56, Issue 7, 2007, Pages 1030-1032

  Corradini, Elena ^a   Ferrara, Francesco ^a   Pollicino, Teresa ^b   Vegetti, Alberto ^a   Abbati, Gian Luca ^a   Losi, Luisa ^a   Raimondo, Giovanni ^b   Pietrangelo, Antonello ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; GENE PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; DISEASE COURSE; FERROPORTIN DISEASE; GENE MUTATION; HUMAN; IRON OVERLOAD; LETTER; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER NODULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; ULTRASOUND;

CARCINOMA, HEPATOCELLULAR; CATION TRANSPORT PROTEINS; DISEASE PROGRESSION; HUMANS; IRON OVERLOAD; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 34347270238     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.122549     Document Type: Letter

References (9)

1. Pietrangelo A, Montosi G, Totaro A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene [see comments]. N Engl J Med 1999;341:725-32.
2. Montosi G, Donovan A, Totaro A, et al. Autosomaldominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
3. Devalia V, Carter K, Walker AP, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-7.
4. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004;32:131-8.
5. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004;1:98-105.
6. Manifold IH, Triger DR, Underwood JC. Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 1983;2:431-3.
7. Zhang W, Arii S, Sasaoki T, et al. The role of Kupffer cells in the surveillance of tumor growth in the liver. J Surg Res 1993;55:140-6.
8. Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci USA 2000;97: 12770-5.
9. Puisieux A, Ponchel F, Ozturk M. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells. Oncogene 1993;8:487-90.